Changes in Patent Law for Life Sciences


January 31, 2013
11:00 am – 12:00 pm EST

 

Sponsored by
Feeney Law Group
 

Symposium Course Description: Recent court cases have called into question what is patentable in the life sciences and bio-it industries. This symposium will present the America Invent Act (AIA) and discuss how these recent rule changes, as of January 10, 2013, affect the patenting process. Several Supreme Court and Federal Circuit Court cases will be presented, as well as how they affect the patentability of molecules, treatments and life sciences IT. Strategies for improving the drafting of patent applications in light of the changes in the law using licenses to best protect your assets, and methods to best monetize those IP decisions will be presented. There will also be a review of the recent USPTO Roundtable discussion on genetic testing and whether it can be patented or not.

Learning Objective Bullet Points: 

  • Recent changes in Intellectual Property Law that every inventor needs to know to better protect their Intellectual Property assets
  • Licensing strategies for optimal monetization of Intellectual Property Assets
  • Management of Intellectual Property portfolio
  • Optimal prior art searching techniques

 

Who Should Attend: 
Scientists, Life Science IT professionals, CEO, COO, business development professionals, entrepreneurs, risk managers

Program Agenda: 

11:00 – 11:05 AM – Intro and Review of Agenda – Moderator
11:05 – 11:20 AM – Alan Feeney, Recent Developments
11:20 – 11:35 AM – Lucy Billings, Licensing
11:35 – 11:45 AM – Donna Bobrick, Patent Searches
11:45 – 12:00 PM – Questions and Answers

Speaker Information:

Alan Feeney, J.D., LL.M., Principal/IP Counsel, Feeney Law Group
Feeney Law Group
255 Promenade Street, Suite 245
Providence, RI 02908
(401) 383-9525
www.feeneylawgroup.com 

Alan has over 22 years of legal experience as a lawyer and over 15 years specializing in intellectual property law. Working as the U.S. Patent Counsel for IPSEN located in Paris, France, Alan developed intellectual property strategies to protect the company’s peptide and protein products and drug development candidates. He successfully drafted and defended approximately 100 patents. While at IPSEN, Alan also served as patent counsel for many international joint ventures and partnerships.

Alan graduated in 1997 from the University of New Hampshire with a Master of Laws in Intellectual Property degree (LL.M.). He earned his Juris Doctor degree from the University of Miami School of Law in 1990. He holds a Bachelor of Science degree in Chemistry from Boston College.

Lucy Billings, J.D., Transactional and Intellectual Property Attorney
Feeney Law Group
255 Promenade Street, Suite 245
Providence, RI 02908
(401) 383-9525
www.feeneylawgroup.com 

Donna Bobrick., Technology Specialist, Feeney Law Group
Feeney Law Group
255 Promenade Street, Suite 245
Providence, RI 02908
(401) 383-9525
www.feeneylawgroup.com 

Moderator:
Donald Frugé, MPH, Executive Director, Feeney Law Group

Feeney Law Group
255 Promenade Street, Suite 245
Providence, RI 02908
(401) 383-9525
www.feeneylawgroup.com 


Upcoming Presentation at the 2013 Molecular Med Tri-Con: 

Mr. Feeney will be presenting at the 2013 Molecular Med Tri-Con (February 13 – 15, 2013 in San Francisco) in the Personalized Diagnostics Program, on February 14 from 3:30 – 3:45 p.m. The topic of his presentation will be “What Everyone Working in the Life Sciences Needs to Know About AIA and the Recent SCOTUS/Federal Circuit Decisions” for more information visit www.triconference.com.



Download Webinar 




By Series:
By Region: